Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Non-Current Assets (2019 - 2023)

Historic Non-Current Assets for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to $91.3 million.

  • ADC Therapeutics' Non-Current Assets fell 251.76% to $91.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $91.3 million, marking a year-over-year decrease of 251.76%. This contributed to the annual value of $83.2 million for FY2022, which is 8951418.26% up from last year.
  • Latest data reveals that ADC Therapeutics reported Non-Current Assets of $91.3 million as of Q3 2023, which was down 251.76% from $94.5 million recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Non-Current Assets registered a high of $96.0 million during Q2 2022, and its lowest value of $14717.0 during Q2 2020.
  • Its 5-year average for Non-Current Assets is $61.4 million, with a median of $76.6 million in 2021.
  • Its Non-Current Assets has fluctuated over the past 5 years, first surged by 47522785.21% in 2021, then plummeted by 691.37% in 2023.
  • Quarter analysis of 5 years shows ADC Therapeutics' Non-Current Assets stood at $15076.0 in 2019, then increased by 0.21% to $15107.0 in 2020, then skyrocketed by 75206.13% to $11.4 million in 2021, then surged by 630.92% to $83.2 million in 2022, then rose by 9.8% to $91.3 million in 2023.
  • Its Non-Current Assets was $91.3 million in Q3 2023, compared to $94.5 million in Q2 2023 and $87.7 million in Q1 2023.